Literature DB >> 7543873

Lymphocyte recognition elements on the VP1 protein of Theiler's virus.

E J Usherwood1, I C Johnston, L J Lovelidge, P Tonks, A A Nash.   

Abstract

Theiler's virus is a murine picornavirus that persists in the central nervous system in susceptible mouse strains, and gives rise to immune mediated demyelinating disease. Antiviral CD4 T cells are necessary to protect from overwhelming virus replication in the acute phase of the disease, and are thought to act by stimulating the antibody response. The present study used overlapping synthetic peptides to map the location of epitopes recognized by CD4 T cells. One T-cell epitope was identified between amino acids 33-47 of VP1, which was recognized by virus-reactive T cells. 'Cryptic' epitopes were also present within VP1 at positions 153-167, 166-180, 225-239 and 233-247. A linear B-cell epitope was identified in the C-terminal region 225-276. Immunization of CBA mice with inactivated virus, but not peptides containing VP1 B- or T-cell epitopes, reduced the virus titre in the CNS in the acute phase of the disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543873      PMCID: PMC1383880     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Characterization and specificity of humoral immune responses to Theiler's murine encephalomyelitis virus capsid proteins.

Authors:  R J Clatch; D C Pevear; E Rozhon; R P Roos; S D Miller; H L Lipton
Journal:  J Gen Virol       Date:  1987-12       Impact factor: 3.891

Review 2.  Lymphocyte recognition of picornaviruses.

Authors:  E J Usherwood; A A Nash
Journal:  J Gen Virol       Date:  1995-03       Impact factor: 3.891

3.  Trypsin-sensitive neutralization site on VP1 of Theiler's murine encephalomyelitis viruses.

Authors:  Y Ohara; A Senkowski; J L Fu; L Klaman; J Goodall; M Toth; R P Roos
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

4.  Preparation and characterization of encephalomyocarditis (EMC) virus.

Authors:  R R Rueckert; M A Pallansch
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

5.  Effect of cyclosporin A, silica quartz dust, and protease inhibitors on virus-induced demyelination.

Authors:  M Rodriguez; J Quddus
Journal:  J Neuroimmunol       Date:  1986-12       Impact factor: 3.478

6.  Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. II. Survey of host immune responses and central nervous system virus titers in inbred mouse strains.

Authors:  R J Clatch; H L Lipton; S D Miller
Journal:  Microb Pathog       Date:  1987-11       Impact factor: 3.738

7.  Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs.

Authors:  R J Clatch; H L Lipton; S D Miller
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

8.  Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice: critical importance of timing of treatment.

Authors:  A Friedmann; G Frankel; Y Lorch; L Steinman
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

9.  The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice.

Authors:  C J Welsh; P Tonks; A A Nash; W F Blakemore
Journal:  J Gen Virol       Date:  1987-06       Impact factor: 3.891

10.  Cellular immunity in chronic Theiler's virus central nervous system infection.

Authors:  S G Rabinowitz; H L Lipton
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

View more
  5 in total

1.  Major linear antibody epitopes and capsid proteins differentially induce protective immunity against Theiler's virus-induced demyelinating disease.

Authors:  H Yahikozawa; A Inoue; C S Koh; Y K Choe; B S Kim
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

2.  Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis.

Authors:  I J McCright; I Tsunoda; F G Whitby; R S Fujinami
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  Theiler's virus infection induces a predominant pathogenic CD4+ T cell response to RNA polymerase in susceptible SJL/J mice.

Authors:  Young-Hee Jin; Bongsu Kang; Byung S Kim
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

Review 4.  Neuropathogenesis of Theiler's murine encephalomyelitis virus infection, an animal model for multiple sclerosis.

Authors:  Ikuo Tsunoda; Robert S Fujinami
Journal:  J Neuroimmune Pharmacol       Date:  2009-11-06       Impact factor: 4.147

5.  Genetic heterogeneity in the leader and P1-coding regions of foot-and-mouth disease virus serotypes A and O in Africa.

Authors:  M Chitray; T A P de Beer; W Vosloo; F F Maree
Journal:  Arch Virol       Date:  2013-11-13       Impact factor: 2.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.